Literature DB >> 1239461

Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism.

T K Sinha, S Miller, J Feming, R Khairi, J Edmondson, C C Johnston, N H Bell.   

Abstract

It had been reported previously that there is a diurnal variation in serum parathyroid hormone (PTH) in normal subjects but not in patients with primary hyperparathyroidism. Studies were performed to determine whether there is a diurnal variation in serum PTH in primary or secondary hyperparathyroidism and whether the nocturnal increase in serum PTH, if present, could be prevented by induced hypercalcemia. Serum PTH and calcium were measured in five normal subjects, two patients with pseudohypoparathyroidism, and fourteen patients with primary hyperparathyroidism, twelve of whom were subsequently found to have parathyroid adenomas. In the normals, there was a mean decline in serum PTH of 0.07 ng/ml before noon and a mean increase of 0.04 ng/ml after 8 PM. In primary hyperparathyroidism there was a mean decline in serum PTH before noon of 0.11 ng/ml and a mean increase of 0.11 ng/ml after 8 PM. In both groups, the lowest mean serum calcium values were noted between midnight and 6:00 AM. Patients with pseudohypoparathyroidism showed a nocturnal increase in serum PTH. In each of two normal subjects, two patients with primary hyperparathyroidism, and two patients with pseudohypoparathyroidism, calcium, 4 mg/kg body weight per hour for 4 hours (8:00 PM to 12 midnight), produced hypercalcemia and prevented the nocturnal increase in serum PTH. We have concluded that a diurnal variation in serum PTH often occurs in both normal subjects and in patients with primary or secondary hyperparathyroidism and that nocturnal increases in serum PTH can be prevented by induced hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1239461     DOI: 10.1210/jcem-41-6-1009

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

2.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

3.  Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.

Authors:  P W Lambert; B W Hollis; N H Bell; S Epstein
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

4.  Effects of 1,25 dihydroxyvitamin D3 administration on circadian mineral rhythms in humans.

Authors:  M E Markowitz; J F Rosen; M Mizruchi
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

5.  Evaluation of postural parathyroid hormone change in patients with primary hyperparathyroidism.

Authors:  Cevdet Aydin; Sefika Burcak Polat; Ahmet Dirikoc; Berna Ogmen; Neslihan Cuhaci; Reyhan Ersoy; Bekir Cakir
Journal:  Int J Endocrinol       Date:  2014-09-01       Impact factor: 3.257

6.  Radioactive Parathyroid Adenomas on Sestamibi Scans: Low Parathyroid Hormone Secretory Potential and Large Volume.

Authors:  Sung Hye Kong; Jung Hee Kim; Sang Wan Kim; Chan Soo Shin
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.